Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I C Haznedaroglu

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Nature|November 21, 1998
Time to take a healthier view of historyI C Haznedaroglu
Experimental Hematology|January 29, 1999
A local renin--angiotensin system in the bone marrow: hypothesis and cluesI C Haznedaroglu
European Review for Medical and Pharmacological Sciences|January 4, 2022
Tailored tyrosine kinase inhibitor (TKI) treatment of chronic myeloid leukemia (CML) based on current evidenceR Ciftciler, I C Haznedaroglu
Nigerian Journal of Clinical Practice|January 21, 2021
Clinical variations between three different causes of thrombocytopeniaS Akin, I C Haznedaroglu
European Review for Medical and Pharmacological Sciences|October 25, 2016
Local bone marrow renin-angiotensin system in the genesis of leukemia and other malignanciesI C Haznedaroglu, U Y Malkan
European Review for Medical and Pharmacological Sciences|July 4, 2023
Chronic myeloid leukemia, tyrosine kinase inhibitors and cardiovascular systemU Y Malkan, I C Haznedaroglu
European Review for Medical and Pharmacological Sciences|July 1, 2022
Hematological aspects of the COVID-19 syndromeU Y Malkan, I C Haznedaroglu
Blood Purification|September 16, 1998
Hemostatic problems in uremiaI C Haznedaroglu, Y Büyükaşik, Y Erdem
Cancer|August 1, 1997
Extramedullary acute promyelocytic leukemiaM Benekli, M C Savaş, I C Haznedaroglu
The American Journal of Gastroenterology|February 1, 1997
Risk of withdrawing chronic anticoagulation without antithrombotic prophylaxisA Kadayifci, I C Haznedaroglu, M C Savas
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Nature|November 21, 1998
Time to take a healthier view of historyI C Haznedaroglu
Experimental Hematology|January 29, 1999
A local renin--angiotensin system in the bone marrow: hypothesis and cluesI C Haznedaroglu
European Review for Medical and Pharmacological Sciences|January 4, 2022
Tailored tyrosine kinase inhibitor (TKI) treatment of chronic myeloid leukemia (CML) based on current evidenceR Ciftciler, I C Haznedaroglu
Nigerian Journal of Clinical Practice|January 21, 2021
Clinical variations between three different causes of thrombocytopeniaS Akin, I C Haznedaroglu
European Review for Medical and Pharmacological Sciences|October 25, 2016
Local bone marrow renin-angiotensin system in the genesis of leukemia and other malignanciesI C Haznedaroglu, U Y Malkan
European Review for Medical and Pharmacological Sciences|July 4, 2023
Chronic myeloid leukemia, tyrosine kinase inhibitors and cardiovascular systemU Y Malkan, I C Haznedaroglu
European Review for Medical and Pharmacological Sciences|July 1, 2022
Hematological aspects of the COVID-19 syndromeU Y Malkan, I C Haznedaroglu
Blood Purification|September 16, 1998
Hemostatic problems in uremiaI C Haznedaroglu, Y Büyükaşik, Y Erdem
Cancer|August 1, 1997
Extramedullary acute promyelocytic leukemiaM Benekli, M C Savaş, I C Haznedaroglu
The American Journal of Gastroenterology|February 1, 1997
Risk of withdrawing chronic anticoagulation without antithrombotic prophylaxisA Kadayifci, I C Haznedaroglu, M C Savas
Pageof 6